We are live on ! Find out more
NVO

Novo Nordisk

1,350 hedge funds and large institutions have $15.6B invested in Novo Nordisk in 2026 Q2 according to their latest regulatory filings, with 215 funds opening new positions, 464 increasing their positions, 459 reducing their positions, and 117 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 215 | Existing positions closed: 117

27% more funds holding in top 10

Funds holding in top 10: 1114 (+3)

26% more capital invested

Capital invested by funds: $12.4B → $15.6B (+$3.26B)

6% more funds holding

Funds holding: 1,2771,350 (+73)

1% more repeat investments, than reductions

Existing positions increased: 464 | Existing positions reduced: 459

0.01% more ownership

Funds ownership: 9.62%9.62% (+0.01%)

9% less call options, than puts

Call options by funds: $2.35B | Put options by funds: $2.58B

Holders
1,350
Holders Change
+73
Holders Change %
+5.72%
% of All Funds
16.31%
Holding in Top 10
14
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+27.27%
% of All Funds
0.17%
New
215
Increased
464
Reduced
459
Closed
117
Calls
$2.35B
Puts
$2.58B
Net Calls
-$225M
Net Calls Change
+$475M
Name Holding Trade Value Shares
Change
Change in
Stake
VA
251
Vident Advisory
Georgia
$4.02M +$2.02M +46,959 +127%
FFA
252
Farther Finance Advisors
California
$3.98M -$173K -4,035 -5%
AWA
253
Arkadios Wealth Advisors
Georgia
$3.92M -$183K -4,266 -5%
WA
254
WealthTrust Axiom
Pennsylvania
$3.92M +$774K +18,007 +28%
WS
255
Wedbush Securities
California
$3.92M -$49.8K -1,158 -1%
PWS
256
Peloton Wealth Strategists
Indiana
$3.77M +$163K +3,800 +5%
PGFC
257
Peapack-Gladstone Financial Corp
New Jersey
$3.77M -$123K -2,869 -4%
DJSG
258
D.J. St. Germain
Massachusetts
$3.75M -$19K -442 -0.6%
MCM
259
Marathon Capital Management
Maryland
$3.75M -$147K -3,430 -4%
SWP
260
Stratos Wealth Partners
Ohio
$3.67M +$131K +3,045 +4%
ACG
261
Allen Capital Group
Nebraska
$3.67M +$100K +2,339 +3%
PWG
262
Portside Wealth Group
Utah
$3.66M +$85.3K +1,985 +3%
TWC
263
TD Waterhouse Canada
Ontario, Canada
$3.65M +$146K +3,399 +5%
S
264
SignatureFD
Georgia
$3.64M +$952K +22,148 +41%
TI
265
Tidal Investments
Wisconsin
$3.63M -$32.4K -755 -1%
EI
266
EFG International
$3.61M +$445K +10,368 +16%
TIM
267
Tevis Investment Management
Texas
$3.6M +$44K +1,025 +1%
GS
268
GTS Securities
Florida
$3.6M +$3.22M +75,048 New
NA
269
NewEdge Advisors
Louisiana
$3.59M -$232K -5,402 -7%
TVPW
270
Third View Private Wealth
Connecticut
$3.56M -$268K -6,228 -8%
LI
271
Lafayette Investments
Maryland
$3.52M +$44.9K +1,044 +1%
FA
272
Fountainhead AM
New Jersey
$3.5M +$659K +15,338 +27%
FGA
273
Fortis Group Advisors
New Jersey
$3.5M +$1.86M +43,213 +145%
MA
274
Mutual Advisors
Nebraska
$3.47M +$127K +2,960 +4%
AWM
275
Apollon Wealth Management
South Carolina
$3.47M +$700K +16,301 +29%

NVO Hedge Fund Activity: Q2 2026 in Review

1,350 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2026, worth a combined $15.6B — up 26% from $12.4B a quarter earlier.

Buyers outnumbered sellers: 215 funds opened new NVO positions and 117 closed out — a net gain of 98 holders — while 464 added to existing stakes and 459 trimmed.

The largest buyer was Fred Alger Management, opening a new position worth an estimated $211M. The largest seller was Susquehanna International Group, cutting an estimated $270M.

  • 1,350 institutional investors held Novo Nordisk (NVO) as of Q2 2026, up from 1,277 in Q1 2026.
  • Funds reported $15.6B of Novo Nordisk stock for Q2 2026, up 26% quarter-over-quarter.
  • 215 funds opened new Novo Nordisk positions in Q2 2026 and 117 closed out, a net change of +98 holders.
  • The largest Novo Nordisk buyer in Q2 2026 was Fred Alger Management, an estimated $211M added.
  • The largest Novo Nordisk seller in Q2 2026 was Susquehanna International Group, an estimated $270M sold.

Based on aggregated 13F filings for Q2 2026.